-
3
-
-
0035152395
-
Evaluation of tests based on individual versus population modelling to compare dissolution curves
-
Comets, E., Mentré, F. (2001). Evaluation of tests based on individual versus population modelling to compare dissolution curves. Journal of Biopharmaceutical Statistics 11:107-123.
-
(2001)
Journal of Biopharmaceutical Statistics
, vol.11
, pp. 107-123
-
-
Comets, E.1
Mentré, F.2
-
4
-
-
0033618483
-
A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption
-
Dunne, A. J., O'Hara, T., Devane, J. (1999). A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption. Statistics in Medicine 18:1865-1876.
-
(1999)
Statistics in Medicine
, vol.18
, pp. 1865-1876
-
-
Dunne, A.J.1
O'Hara, T.2
Devane, J.3
-
5
-
-
19944416570
-
Deconvolution based approach for level A in vivo-in vitro correlation modelling: Statistical considerations
-
Dunne, A., Gaynor, C., Davis, J. (2005). Deconvolution based approach for level A in vivo-in vitro correlation modelling: statistical considerations. Clinical Research and Regulatory Affairs 22:1-14.
-
(2005)
Clinical Research and Regulatory Affairs
, vol.22
, pp. 1-14
-
-
Dunne, A.1
Gaynor, C.2
Davis, J.3
-
6
-
-
0000655208
-
Guidelines for dissolution testing of solid oral products
-
FIP
-
FIP (1996). Guidelines for dissolution testing of solid oral products. Drug Information Journal 30:1071-1084.
-
(1996)
Drug Information Journal
, vol.30
, pp. 1071-1084
-
-
-
7
-
-
0030806512
-
Convolution-based approaches for in vivo-in vitro correlation modelling
-
Gillespie, W. R. (1997). Convolution-based approaches for in vivo-in vitro correlation modelling. Advances in Experimental Medicine and Biology 423:53-65.
-
(1997)
Advances in Experimental Medicine and Biology
, vol.423
, pp. 53-65
-
-
Gillespie, W.R.1
-
8
-
-
0021842586
-
Gastro-intestinal bioavailability: Determination of in vivo release profiles of solid dosage forms by deconvolution
-
Gillespie, W. R., Veng-Pedersen, P. (1985). Gastro-intestinal bioavailability: determination of in vivo release profiles of solid dosage forms by deconvolution. Biopharmaceutics and Drug Disposition 6:351-355.
-
(1985)
Biopharmaceutics and Drug Disposition
, vol.6
, pp. 351-355
-
-
Gillespie, W.R.1
Veng-Pedersen, P.2
-
9
-
-
1542724956
-
Interpretation and optimization of the dissolution specifications for a modified release product with an in vivo-in vitro correlation (IVIVC)
-
Hayes, S., Dunne, A., Smart, T., Davis, J. (2004). Interpretation and optimization of the dissolution specifications for a modified release product with an in vivo-in vitro correlation (IVIVC). Journal of Pharmaceutical Sciences 93:571-581.
-
(2004)
Journal of Pharmaceutical Sciences
, vol.93
, pp. 571-581
-
-
Hayes, S.1
Dunne, A.2
Smart, T.3
Davis, J.4
-
10
-
-
0036023387
-
Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease
-
Lilienfeld, S. (2002). Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease. CNS Drug Reviews 8:159-176.
-
(2002)
CNS Drug Reviews
, vol.8
, pp. 159-176
-
-
Lilienfeld, S.1
-
12
-
-
0034434385
-
Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications
-
Modi, N. B., Lam, A., Lindemulder, E., Wang, B., Gupta, S. K. (2000). Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications. Biopharmaceutics and Drug Disposition 21:321-326.
-
(2000)
Biopharmaceutics and Drug Disposition
, vol.21
, pp. 321-326
-
-
Modi, N.B.1
Lam, A.2
Lindemulder, E.3
Wang, B.4
Gupta, S.K.5
-
14
-
-
0034958401
-
In vivo-in vitro correlation (IVIVC) modelling incorporating a convolution step
-
O'Hara, T., Hayes, S., Davis, J., Devane, J., Smart, T., Dunne, A. (2001). In vivo-in vitro correlation (IVIVC) modelling incorporating a convolution step. Journal of Pharmacokinetics and Pharmacodynamics 28:277-298.
-
(2001)
Journal of Pharmacokinetics and Pharmacodynamics
, vol.28
, pp. 277-298
-
-
O'Hara, T.1
Hayes, S.2
Davis, J.3
Devane, J.4
Smart, T.5
Dunne, A.6
-
15
-
-
0037407951
-
Galantamine population pharmacokinetics in patients with alzheimer's disease: Modelling and simulations
-
Piotrovsky, V., Van Peer, A., Van Osselaer, N., Armstrong, M., Aerssens, J. (2003). Galantamine population pharmacokinetics in patients with alzheimer's disease: modelling and simulations. Journal of Clinical Pharmacology 43:514-523.
-
(2003)
Journal of Clinical Pharmacology
, vol.43
, pp. 514-523
-
-
Piotrovsky, V.1
Van Peer, A.2
Van Osselaer, N.3
Armstrong, M.4
Aerssens, J.5
-
16
-
-
0033759666
-
Carbamazepine level-A in vivo-in vitro correlation (IVIVC): A scaled convolution based predictive approach
-
Veng-Pedersen, P., Gobburu, J. V. S., Meyer, M.C., Straughn, A. B. (2000). Carbamazepine level-A in vivo-in vitro correlation (IVIVC): a scaled convolution based predictive approach. Biopharmaceutics and Drug Disposition 21:1-6.
-
(2000)
Biopharmaceutics and Drug Disposition
, vol.21
, pp. 1-6
-
-
Veng-Pedersen, P.1
Gobburu, J.V.S.2
Meyer, M.C.3
Straughn, A.B.4
|